Benzinga | Oct 16, 2020 05:42AM EDT

Wedbush Initiates Coverage On Adicet Bio with Outperform Rating, Announces Price Target of $25

Wedbush analyst Robert Driscoll initiates coverage on Adicet Bio (NASDAQ:ACET) with a Outperform rating and announces Price Target of $25.